Medicine guide

CORIFACT

As listed in the register: CORIFACT 250

250 unit · powder for solution

  • Prescription status not stated
  • Blood, clotting and anaemia
Active substance
Factor Xiii
Made by
Csl Behring Canada Inc

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupBlood, clotting and anaemiaB02BD07

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byCsl Behring Canada Inc
Active substanceFactor Xiii
Used inBlood, clotting and anaemia
Strength250 unit
Formpowder for solution
ClassificationB02BD07 · Blood, clotting and anaemia
Routeintravenous
Dispensing (as stated by the register)SCHEDULE D
StatusMarketed
MarketedYes, according to the register
Name in the registerCORIFACT 250
DIN02418738
DPD drug code90329

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

  • powder for solution2 products

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.